BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 21166558)

  • 1. The pharmaceutical pipeline for atrial fibrillation.
    Santangeli P; Di Biase L; Pelargonio G; Burkhardt JD; Natale A
    Ann Med; 2011 Feb; 43(1):13-32. PubMed ID: 21166558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New antiarrhythmic drugs for treatment of atrial fibrillation.
    Dobrev D; Nattel S
    Lancet; 2010 Apr; 375(9721):1212-23. PubMed ID: 20334907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vernakalant: a novel antiarrhythmic drug for the rapid conversion of atrial fibrillation to sinus rhythm].
    Hirt MN; Eschenhagen T
    Dtsch Med Wochenschr; 2010 May; 135(19):971-6. PubMed ID: 20446233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmenting maintenance of sinus rhythm in the control of atrial fibrillation by antiarrhythmic drug combinations.
    Singh BN
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):31S-5S. PubMed ID: 21098417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New antiarrhythmic drugs for atrial fibrillation: focus on dronedarone and vernakalant.
    Camm AJ; Savelieva I
    J Interv Card Electrophysiol; 2008 Oct; 23(1):7-14. PubMed ID: 18523740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial-selective pharmacological therapy for atrial fibrillation: hype or hope?
    Ehrlich JR; Nattel S
    Curr Opin Cardiol; 2009 Jan; 24(1):50-5. PubMed ID: 19077816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dronedarone: an emerging therapy for atrial fibrillation.
    Rosei EA; Salvetti M
    Ther Adv Cardiovasc Dis; 2010 Jun; 4(3):155-64. PubMed ID: 20418270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the treatment of atrial fibrillation.
    Miranda RI; Simpson CS; Michael KA; Abdollah H; Baranchuk AM; Redfearn DP
    Minerva Cardioangiol; 2010 Dec; 58(6):637-48. PubMed ID: 21135805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone.
    Krishnamoorthy S; Lip GY
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):473-81. PubMed ID: 19419255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New antiarrhythmic drugs for treatment of atrial fibrillation].
    Raatikainen MJ; Huikuri HV
    Duodecim; 2010; 126(19):2255-62. PubMed ID: 21086684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vernakalant--a new drug for pharmacological conversion of atrial fibrillation].
    Hinneburg I
    Med Monatsschr Pharm; 2011 May; 34(5):154-8. PubMed ID: 21644373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
    Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vernakalant hydrochloride for the treatment of atrial fibrillation.
    Kozlowski D; Budrejko S; Lip GY; Mikhailidis DP; Rysz J; Raczak G; Banach M
    Expert Opin Investig Drugs; 2009 Dec; 18(12):1929-37. PubMed ID: 19938903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dronedarone therapy in atrial fibrillation: a summary of recent controlled trials.
    Duray GZ; Schmitt J; Hohnloser SH
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):19S-23S. PubMed ID: 20472812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of vernakalant hydrochloride injection for rapid conversion of atrial fibrillation.
    Pratt CM; Roy D; Torp-Pedersen C; Wyse DG; Toft E; Juul-Moller S; Retyk E; Drenning DH;
    Am J Cardiol; 2010 Nov; 106(9):1277-83. PubMed ID: 21029824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New anthyarrhythmic drugs for atrial fibrillation.
    Matassini MV; Guerra F; Scappini L; Urbinati A; Capucci A
    Future Cardiol; 2015; 11(6):705-17. PubMed ID: 26631497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dronedarone: an amiodarone analog for the treatment of atrial fibrillation and atrial flutter.
    Dale KM; White CM
    Ann Pharmacother; 2007 Apr; 41(4):599-605. PubMed ID: 17389667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.
    Savelieva I; Kakouros N; Kourliouros A; Camm AJ
    Europace; 2011 Mar; 13(3):308-28. PubMed ID: 21345926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dronedarone.
    Patel C; Yan GX; Kowey PR
    Circulation; 2009 Aug; 120(7):636-44. PubMed ID: 19687370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dronedarone: a new antiarrhythmic agent for the treatment of atrial fibrillation.
    Garcia D; Cheng-Lai A
    Cardiol Rev; 2009; 17(5):230-4. PubMed ID: 19690474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.